Selective Serotonin Reuptake Inhibitors (SSRIs) Market Outlook (2025–2034)

The global Selective Serotonin Reuptake Inhibitors (SSRIs) market is projected to grow at a CAGR of 4.20% during the forecast period of 2025–2034, driven by the rising geriatric population and increasing prevalence of mental health conditions such as depression and anxiety. SSRIs remain a primary treatment option due to their effectiveness and favorable side-effect profile, contributing to consistent market demand across key global regions.